NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

BACKGROUND: Programmed cell death ligand-1 (PD-L1) expression as a single biomarker for immune checkpoint blockade (ICB) was controversial. NKG2A was a PD1/PD-L1 axis-related immunity-dependent factor. NKG2A and PD-L1 expression as a combinatorial biomarker might improve the prediction of PD-L1 in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Sen, Zeng, Han, Jin, Kaifeng, Shao, Fei, Liu, Zhaopei, Chang, Yuan, Wang, Yiwei, Zhu, Yu, Wang, Zewei, Xu, Le, Xu, Jiejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073407/
https://www.ncbi.nlm.nih.gov/pubmed/35523436
http://dx.doi.org/10.1136/jitc-2022-004569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073407/
https://www.ncbi.nlm.nih.gov/pubmed/35523436
http://dx.doi.org/10.1136/jitc-2022-004569

Ejemplares similares